Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
28022
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (2)
- 12/10/17 12/10/17 -
- 1/2/18 1/2/18 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
December 10, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
End of study GOAL Trial B-cell Lymphoma NCT02499003
End of study GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
End of study GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Date of study end
Item
Date of study end
date
follow-up completion
Item
Did the subject complete the follow-up?
boolean
Item
If 'no', please specify reason(s) for early follow-up termination:
text
Code List
If 'no', please specify reason(s) for early follow-up termination:
CL Item
Withdrawal of consent (Withdrawal of consent)
CL Item
Death (Death)
CL Item
Lost to Follow-Up (Lost to Follow-Up)
CL Item
Other (Other)
Date of death
Item
If 'death': Date
date
CL Item
Progression of underlying disease (Progression of underlying disease)
CL Item
Unknown (Unknown)
CL Item
Other (Other)
other reason for early follow-up termination
Item
If 'other' reason for early follow-up termination, please specify:
text